A clinical study found that there is a 65% greater chance of improvement in the condition of patients with severe conditions treated with Ramdesibir compared to conventional treatment.

• Ramdsibir. Good results in treating difficult corona patients

  Photo: 

  Reuters

The drug that has been found to be more effective: There is a 65% greater chance of improvement in the clinical index of corona patients treated with Ramdesibir, compared to conventional treatment to date, according to a recent clinical study. Ramadsibir is a drug developed against the Ebola virus, but studies have found that it also helps to cope with corona disease.

The study looked at the efficacy of Ramdesibir in five and 10 days of treatment. As part of the study, the clinical metrics of patients on day 11 were examined in terms of their condition at discharge from the hospital, an increase in blood oxygen levels, and a need for ventilation or mortality.

The results of the study indicated that patients treated for five days in Ramdesibir had a 65% greater chance of improvement in clinical indices compared to the non-drug control group.

More on:

• FDA approved - a cure for corona treatment

• New research: encouraging results for the drug for Corona

• Medicines for SARS and West Nile Fever: The treatments to help beat the Corona?

In early May, the US Drug Administration (FDA) granted emergency approval for the use of Ramdesibir as part of the Corona fight, after positive results in using the drug.